Manuel Ruiz Muñoz

ORCID: 0000-0002-8360-7443
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Systemic Sclerosis and Related Diseases
  • Dermatologic Treatments and Research
  • Dermatological and Skeletal Disorders
  • Mast cells and histamine
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Autoimmune and Inflammatory Disorders Research
  • Acute Ischemic Stroke Management
  • Parvovirus B19 Infection Studies
  • Inflammatory Myopathies and Dermatomyositis
  • Liver physiology and pathology
  • Ethics and bioethics in healthcare
  • Hidradenitis Suppurativa and Treatments
  • Cerebral Venous Sinus Thrombosis
  • Spanish Culture and Identity
  • Adolescent and Pediatric Healthcare
  • COVID-19 and healthcare impacts
  • Urinary Tract Infections Management
  • Atrial Fibrillation Management and Outcomes
  • Cancer Immunotherapy and Biomarkers
  • Cinema History and Criticism
  • Media, Journalism, and Communication History
  • Inflammatory Bowel Disease
  • Statistics Education and Methodologies
  • Immune Cell Function and Interaction
  • Liver Diseases and Immunity

Hospital Universitario Fundación Alcorcón
2013-2024

Universidad Rey Juan Carlos
2024

Bellvitge University Hospital
2022

Institut d'Investigació Biomédica de Bellvitge
2022

Biomedical Research and Innovation Institute of Cadiz
2022

Universidad de Cádiz
2022

To characterize the etiologies and clinical features at diagnosis of patients with hemophagocytic lymphohistiocytosis (HLH) correlate these baseline survival using an etiopathogenically guided multivariable model.The Spanish Group Autoimmune Diseases HLH Study Group, formed in 2013, is aimed collecting adult diagnosed internal medicine departments between January 3, October 28, 2017.The cohort consisted 151 (91 men; mean age, 51.4 years). After a follow-up 17 months (range, 1-142 months), 80...

10.1016/j.mayocpiqo.2018.06.006 article EN cc-by-nc-nd Mayo Clinic Proceedings Innovations Quality & Outcomes 2018-08-01

10.1007/s10067-017-3936-7 article EN Clinical Rheumatology 2017-12-06

Abstract Background This study was designed to evaluate if patients with high risk for severe coronavirus disease 2019 (COVID-19) would benefit from treatment tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) followed by baricitinib in case of hypoxemia and systemic inflammation. Methods PANCOVID is an open-label, double-randomized, phase 3 pragmatic clinical trial including adults symptomatic COVID-19 ≥2 comorbidities or aged ≥60 years conducted between 10 October 2020 23 September...

10.1093/cid/ciac628 article EN Clinical Infectious Diseases 2022-07-30

<ns4:p><ns4:bold>Background: </ns4:bold>Colitis is a frequent immune-related toxicity, without any biomarker that may predict its onset. It endoscopically similar to intestinal inflammatory diseases, where fecal calprotectin (FC) used as early-detect relapse. We found contradictory evidence about FC and immunotherapy no prospective study was already published. </ns4:p><ns4:p> <ns4:bold>Methods</ns4:bold>: present an analytical, observational of one year’s duration. analyzed basal, then prior...

10.12688/f1000research.53327.1 preprint EN cc-by F1000Research 2021-07-05

<h3>Background</h3> HScore is a numeric scoring system recently proposed by Fardet et al in 2014, designed to estimate the risk of having hemophagocytic syndrome (HS) adults. <h3>Objectives</h3> The objective this study analyze potential use as prognostic factor large cohort Spanish patients with adult HS. <h3>Methods</h3> In June 2013, Study Group Autoimmune Diseases (GEAS-SEMI) created National Registry Adult Patients were diagnosed according fulfillment Histiocytosis Society criteria 1991...

10.1136/annrheumdis-2015-eular.4821 article EN Annals of the Rheumatic Diseases 2015-06-01

<h3>Objectives</h3> To characterise the etiologies and clinical features at diagnosis of patients with hemophagocytic lymphohistiocytosis (HLH) correlate these baseline survival using an etiopathogenically-guided multivariate model. <h3>Methods</h3> The HLH Study Group Spanish Autoimmune Diseases (GEAS) was formed in 2013 aim collecting a large series adult substantial experience management systemic diseases. By October 2017, database included 151 consecutive who fulfilled least 5 8 criteria...

10.1136/annrheumdis-2018-eular.4112 article EN Annals of the Rheumatic Diseases 2018-06-01

Objective: Endocannabinoid system (ES) seems to be altered in patients with depression. Cardiorespiratory fitness (CRF) may an interacting factor the relationship between ES biomarkers and depressive symptoms people diagnosed The aim was study role of CRF on possible association 73 adults &#x0D; Method: This examine outcomes cardiorespiratory plasma levels lipid mediators; anandamide (AEA) 2-arachidonoylglycerol (2-AG) sampled from depression.&#x0D; Results: Patients high level had...

10.33155/j.ramd.2022.08.001 article EN Revista Andaluza de Medicina del Deporte 2022-08-04
Coming Soon ...